15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering eHealth Inc, 0 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $1.75 to $2.00, so the covering firms are broadly aligned. The average target of $1.92 sits 93% above the current $0.99. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.91 next quarter toward $-0.98 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Hold
Strong Buy00%
Buy00%
Hold3100%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to eHealth Inc.
As of Sep, 0 of 3 firms rate EHTH a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
EHTH EPS & revenue forecast
EPS · NEXT QUARTER
$1.91
Range $1.78 – $2.02 · 3 analysts · -7% YoY
Next period, 3 analysts expect eHealth Inc to earn $1.91 a share (range $1.78 – $2.02), versus $2.06 a year earlier. Full-year consensus is $-1.27, growing to $-0.98 the year after.
REVENUE · NEXT QUARTER
$273.7M
Range $267.0M – $279.5M · 3 analysts · -16% YoY
Revenue is expected to reach $273.7M (range $267.0M – $279.5M), -16.1% year-over-year. Full-year consensus is $422.4M, rising to $435.3M next year.
Top analysts covering eHealth Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EHTH.
#1
George Sutton
Craig-Hallum · Rank #139
Hold
No targeton EHTH
Overall win rate
35%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #149
Hold
$2.00+101.5% to target
Overall win rate
44%
+ Follow
#3
JY
Jonathan Yong
UBS
Hold
$1.75+76.3% to target
Coverage
—
+ Follow
#4
George Hill
Deutsche Bank
Hold
$3.00+202.2% to target
Coverage
—
+ Follow
#5
AK
Adam Klauber
William Blair
Hold
No targeton EHTH
Coverage
—
+ Follow
EHTH stock forecast FAQ
What is EHTH's average 12-month price target?+
The 3 analysts with a live target average $1.92 for eHealth Inc over the next 12 months, ranging from a $2.00 high to a $1.75 low.
Is EHTH stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 3 analyst ratings, 0 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for EHTH?+
The Street-high target is $2.00 (RBC Capital), and the Street-low is $1.75 (UBS). The average of all 3 active targets is $1.92.
How many Wall Street analysts cover EHTH?+
3 analysts have an active rating on eHealth Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering EHTH?+
Among analysts who currently cover EHTH, George Sutton of Craig-Hallum has the strongest overall Quantellect track record (Rank #139). Their current call is Hold.
What is eHealth Inc's projected EPS for next quarter?+
The consensus estimate is $1.91 per share (range $1.78 – $2.02) across 3 analysts. Full-year EPS is projected at $-1.27, rising to $-0.98 the following year.
How much revenue is eHealth Inc expected to report next quarter?+
Consensus revenue is $273.7M (range $267.0M – $279.5M). Full-year revenue is projected at $422.4M, growing to $435.3M next year.
Have analysts been upgrading or downgrading EHTH lately?+
As of Sep, 0 of 3 firms rate EHTH a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EHTH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
